Cargando…

NRF3 Decreases during Melanoma Carcinogenesis and Is an Independent Prognostic Marker in Melanoma

The prognostic significance of the major redox regulator, nuclear factor erythroid-2-related factor 2 (NRF2), is recognized in many cancers, but the role of NRF3 is not studied. Analysis from the Gene Expression Omnibus datasets showed that NRF3 mRNA levels increased from benign to dysplastic naevi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Immonen, Anni, Haapasaari, Kirsi-Maria, Skarp, Sini, Karihtala, Peeter, Teppo, Hanna-Riikka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976671/ https://www.ncbi.nlm.nih.gov/pubmed/35378827 http://dx.doi.org/10.1155/2022/2240223

Ejemplares similares

NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs
por: Hämäläinen, Mari, et al.
Publicado: (2019)

Keap1 expression has independent prognostic value in pancreatic adenocarcinomas
por: Isohookana, Joel, et al.
Publicado: (2015)

Redox Regulating Enzymes and Connected MicroRNA Regulators Have Prognostic Value in Classical Hodgkin Lymphomas
por: Karihtala, Peeter, et al.
Publicado: (2017)

The Role of Redox-Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant Chemotherapy
por: Roininen, Nelli, et al.
Publicado: (2017)

Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy
por: Teppo, Hanna-Riikka, et al.
Publicado: (2017)

High-level cytoplasmic claudin 3 expression is an independent predictor of poor survival in triple-negative breast cancer
por: Jääskeläinen, Anniina, et al.
Publicado: (2018)

Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP
por: Kari, Esa, et al.
Publicado: (2019)

Primary neuroendocrine breast carcinomas are associated with poor local control despite favourable biological profile: a retrospective clinical study
por: Roininen, Nelli, et al.
Publicado: (2017)

Oxidative stress and redox state-regulating enzymes have prognostic relevance in diffuse large B-cell lymphoma
por: Peroja, Pekka, et al.
Publicado: (2012)

Comparison of the mutational profiles of neuroendocrine breast tumours, invasive ductal carcinomas and pancreatic neuroendocrine carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2022)

Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma
por: Kuusisto, Milla Elvi Linnea, et al.
Publicado: (2015)

A UV-independent pathway to melanoma carcinogenesis in the redhair-fairskin background
por: Mitra, Devarati, et al.
Publicado: (2012)

Impact of central nervous system (CNS) prophylaxis on the incidence of CNS relapse in patients with high-risk diffuse large B cell/follicular grade 3B lymphoma
por: Kuitunen, Hanne, et al.
Publicado: (2020)

Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma
por: Leppänen, Joni, et al.
Publicado: (2019)

Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma
por: MATTILA, Kalle, et al.
Publicado: (2023)

Prognostic value of tumor markers in malignant melanoma
por: Treskova, Inka, et al.
Publicado: (2014)

Identification of Versican as an Independent Prognostic Factor in Uveal Melanoma
por: Xu, Jia, et al.
Publicado: (2021)

Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases
por: Furtner, Julia, et al.
Publicado: (2018)

TERT Promoter Mutation as an Independent Prognostic Marker for Poor Prognosis MAPK Inhibitors-Treated Melanoma
por: Blateau, Pauline, et al.
Publicado: (2020)

Validation of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)
por: Nieder, Carsten, et al.
Publicado: (2018)

The mutational signatures of cancer: can passengers set a direction for prognosis?
por: Karihtala, Peeter
Publicado: (2023)

Preoperative serum 8-hydroxydeoxyguanosine is associated with chemoresistance and is a powerful prognostic factor in endometrioid-type epithelial ovarian cancer
por: Pylväs-Eerola, Marjo, et al.
Publicado: (2015)

Prognostic factors in metastatic breast cancer: a prospective single-centre cohort study in a Finnish University Hospital
por: Karihtala, Peeter, et al.
Publicado: (2020)

Prognostic significance of the aberrant expression of neuroendocrine markers in melanomas
por: Wu, Yan, et al.
Publicado: (2021)

Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma
por: Bedin, Valcinir, et al.
Publicado: (2010)

Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOP
por: Peroja, Pekka, et al.
Publicado: (2018)

Cell kinetics: an independent prognostic variable in stage II melanoma of the skin.
por: Costa, A., et al.
Publicado: (1990)

Identification of risk in cutaneous melanoma patients: Prognostic and predictive markers
por: Hyams, David M., et al.
Publicado: (2018)

Novel Prognostic Immunohistochemical Markers in Uveal Melanoma-Literature Review
por: Gajdzis, Malgorzata, et al.
Publicado: (2021)

The Impact of Hyaluronan on Tumor Progression in Cutaneous Melanoma
por: Takabe, Piia, et al.
Publicado: (2022)

NRF2 Enables EGFR Signaling in Melanoma Cells
por: Kreß, Julia Katharina Charlotte, et al.
Publicado: (2021)

SLT-VEGF Reduces Lung Metastases, Decreases Tumor Recurrence, and Improves Survival in an Orthotopic Melanoma Model
por: Ackerman, Rachel, et al.
Publicado: (2010)

Lymph Node Ratio: Is It an Independent Prognostic Factor for Stage III Cutaneous Melanoma?
por: Salari, Abolfazl, et al.
Publicado: (2018)

Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities
por: Rabbie, Roy, et al.
Publicado: (2019)

Prognostic Value of Preoperative Inflammatory Markers in Melanoma Patients with Brain Metastases
por: Schneider, Matthias, et al.
Publicado: (2021)

BAP1 methylation: a prognostic marker of uveal melanoma metastasis
por: Bakhoum, Mathieu F., et al.
Publicado: (2021)

The Transcription Factor Twist1 Has a Significant Role in Mycosis Fungoides (MF) Cell Biology: An RNA Sequencing Study of 40 MF Cases
por: Häyrinen, Marjaana J., et al.
Publicado: (2023)

NRF2 and Key Transcriptional Targets in Melanoma Redox Manipulation
por: Carpenter, Evan L., et al.
Publicado: (2022)

The dual role of Nrf2 in melanoma: a systematic review
por: Malakoutikhah, Zahra, et al.
Publicado: (2023)

Hypoxia-Independent Drivers of Melanoma Angiogenesis
por: Meierjohann, Svenja
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6d1lunj297phcp6jturdi70ue3